Overall Status

Recruiting (18)

Completed (15)

Unknown status (6)

Active, not recruiting (4)

Not yet recruiting (4)

Terminated (4)

Enrolling by invitation (1)

Withdrawn (1)

Phase

phase 2 (22)

phase 1/phase 2 (8)

n/a (7)

phase 1 (3)

phase 3 (3)

phase 4 (3)

early phase 1 (1)

phase 2/phase 3 (1)

Study Documents

Intervention Type

drug (37)

procedure (12)

biological (7)

radiation (7)

other (5)

device (3)

genetic (1)

Funder Type

Other (38)

NIH (13)

Industry (2)

Study Type

Interventional (48)

Observational (3)

Observational [Patient Registry] (2)

severe aplastic anemia

Showing 51 - 53 of 53

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Severe Aplastic Anemia Trial in Tianjin (ATG)

Unknown status

Severe Aplastic Anemia

Tianjin, Tianjin, China

Department of Pediatrics, Institute of Hematology and Blood Dise

Dec 2, 2013

Severe Aplastic Anemia Trial (Cyclophosphamide, Fludarabine, Rabbit ATG)

Withdrawn

Severe Aplastic Anemia

Cyclophosphamide, Fludarabine, Rabbit ATG

(no location specified)

Mar 23, 2012

Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia Trial in San Francisco (Busulfan/Fludarabine

Completed

Chronic Myeloid Leukemia
+8 more

Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF

San Francisco, California

University of California San Francisco

Jan 22, 2009